Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 70700-315

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 70700-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logarithmic Scale.jpg (Image 01)

A forest plot showing odds ratios with 95% confidence intervals on a logarithmic scale for studies evaluating risk related to DMPA use. The x-axis represents odds ratios ranging from 0.6 to 7.4, with a vertical line at 1.0 indicating no increased risk. Individual study data points with confidence intervals are plotted for Lee et al. (1987), Paul et al. (1989), WHO (1991), Shapiro et al. (2000), and Li et al. (2012), including sub-analyses for all subjects and DMPA use greater than or equal to 12 months.*

FDA Label Image

Structure (Image 02)

Chemical structure of Medroxyprogesterone Acetate, showing its molecular arrangement with multiple carbon rings, methyl groups, and acetate functional groups.*

FDA Label Image

Image (Image 03)

A vertical chart displaying pregnancy rates per 100 women in one year, categorized by contraception methods. The chart ranges from fewer than 1 pregnancy (implants, injections, intrauterine devices, sterilization) to 85 or more pregnancies (no birth control). Intermediate methods include birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal, showing increasing pregnancies as methods become less effective.*

FDA Label Image

Carton 1 (Image 04)

Carton label for Medroxyprogesterone Acetate injection, suspension, USP 150 mg/mL by Xiromed LLC. The label indicates the product is an intramuscular contraceptive injection available in 25 single-dose vials of 1 mL each. The design features white and purple colors with dosage and product details prominently displayed.*

FDA Label Image

Carton (Image 05)

Packaging label for Medroxyprogesterone Acetate 150 mg/mL injection, suspension, intramuscular use. The label indicates a single-dose vial of 1 mL. The product is identified as a contraceptive injection by Xiromed LLC and displays the product NDC 70700-315. The label includes dosing instructions and manufacturer details.*

FDA Label Image

Vial (Image 06)

Label for Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL single-dose vial by Xiromed LLC. The label indicates it is for contraceptive injection, intramuscular use only, with an NDC of 70700-315-22. Usage instructions advise referring to prescribing information and shaking vigorously before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.